MRO — Melrose Industries Balance Sheet
0.000.00%
- £6.15bn
- £7.88bn
- £3.59bn
Annual balance sheet for Melrose Industries, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 473 | 355 | 58 | 88 | 166 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,155 | 1,569 | 788 | 921 | 940 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,584 | 2,990 | 1,423 | 1,580 | 1,709 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,528 | 2,599 | 777 | 821 | 864 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,022 | 14,179 | 7,104 | 7,436 | 7,596 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,124 | 3,094 | 1,640 | 1,751 | 1,737 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,515 | 7,050 | 3,537 | 4,592 | 4,769 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7,507 | 7,129 | 3,567 | 2,844 | 2,827 |
| Total Liabilities & Shareholders' Equity | 14,022 | 14,179 | 7,104 | 7,436 | 7,596 |
| Total Common Shares Outstanding |